215 related articles for article (PubMed ID: 20111957)
41. IL-18 and IL-12 synergy induces matrix degrading enzymes in the lung.
Cero FT; Hillestad V; Løberg EM; Christensen G; Larsen KO; Skjønsberg OH
Exp Lung Res; 2012 Oct; 38(8):406-19. PubMed ID: 22908875
[TBL] [Abstract][Full Text] [Related]
42. Thiazolidinediones inhibit TNF-alpha-mediated osteoclast differentiation of RAW264.7 macrophages and mouse bone marrow cells through downregulation of NFATc1.
Yang CR; Lai CC
Shock; 2010 Jun; 33(6):662-7. PubMed ID: 19953004
[TBL] [Abstract][Full Text] [Related]
43. Tacrolimus potently inhibits human osteoclastogenesis induced by IL-17 from human monocytes alone and suppresses human Th17 differentiation.
Yago T; Nanke Y; Kawamoto M; Yamanaka H; Kotake S
Cytokine; 2012 Aug; 59(2):252-7. PubMed ID: 22579702
[TBL] [Abstract][Full Text] [Related]
44. Human periodontal ligament fibroblasts stimulate osteoclastogenesis in response to compression force through TNF-α-mediated activation of CD4+ T cells.
Kook SH; Jang YS; Lee JC
J Cell Biochem; 2011 Oct; 112(10):2891-901. PubMed ID: 21618593
[TBL] [Abstract][Full Text] [Related]
45. Induction of osteoclastogenesis in an in vitro model of Gaucher disease is mediated by T cells via TNF-α.
Mucci JM; Scian R; De Francesco PN; García FS; Ceci R; Fossati CA; Delpino MV; Rozenfeld PA
Gene; 2012 Nov; 509(1):51-9. PubMed ID: 23010424
[TBL] [Abstract][Full Text] [Related]
46. CXC chemokine ligand 2 induced by receptor activator of NF-kappa B ligand enhances osteoclastogenesis.
Ha J; Choi HS; Lee Y; Kwon HJ; Song YW; Kim HH
J Immunol; 2010 May; 184(9):4717-24. PubMed ID: 20357249
[TBL] [Abstract][Full Text] [Related]
47. In vitro investigation of the roles of the proinflammatory cytokines tumor necrosis factor-α and interleukin-1 in murine osteoclastogenesis.
Jules J; Feng X
Methods Mol Biol; 2014; 1155():109-23. PubMed ID: 24788177
[TBL] [Abstract][Full Text] [Related]
48. Phytoestrogens directly inhibit TNF-α-induced bone resorption in RAW264.7 cells by suppressing c-fos-induced NFATc1 expression.
Karieb S; Fox SW
J Cell Biochem; 2011 Feb; 112(2):476-87. PubMed ID: 21268069
[TBL] [Abstract][Full Text] [Related]
49. Fibronectin inhibits osteoclastogenesis while enhancing osteoclast activity via nitric oxide and interleukin-1β-mediated signaling pathways.
Gramoun A; Azizi N; Sodek J; Heersche JN; Nakchbandi I; Manolson MF
J Cell Biochem; 2010 Nov; 111(4):1020-34. PubMed ID: 20672308
[TBL] [Abstract][Full Text] [Related]
50. Regulatory T cells protect from local and systemic bone destruction in arthritis.
Zaiss MM; Frey B; Hess A; Zwerina J; Luther J; Nimmerjahn F; Engelke K; Kollias G; Hünig T; Schett G; David JP
J Immunol; 2010 Jun; 184(12):7238-46. PubMed ID: 20483756
[TBL] [Abstract][Full Text] [Related]
51. T cell-mediated increased osteoclast formation from peripheral blood as a mechanism for Crohn's disease-associated bone loss.
Oostlander AE; Everts V; Schoenmaker T; Bravenboer N; van Vliet SJ; van Bodegraven AA; Lips P; de Vries TJ
J Cell Biochem; 2012 Jan; 113(1):260-8. PubMed ID: 21898548
[TBL] [Abstract][Full Text] [Related]
52. Immunological reaction in TNF-α-mediated osteoclast formation and bone resorption in vitro and in vivo.
Kitaura H; Kimura K; Ishida M; Kohara H; Yoshimatsu M; Takano-Yamamoto T
Clin Dev Immunol; 2013; 2013():181849. PubMed ID: 23762085
[TBL] [Abstract][Full Text] [Related]
53. Membrane-bound CD40 ligand on T cells from mice injected with lipopolysaccharide accelerates lipopolysaccharide-induced osteoclastogenesis.
Yokoyama M; Ukai T; Ayon Haro ER; Kishimoto T; Yoshinaga Y; Hara Y
J Periodontal Res; 2011 Aug; 46(4):464-74. PubMed ID: 21521224
[TBL] [Abstract][Full Text] [Related]
54. Brucella abortus-infected macrophages modulate T lymphocytes to promote osteoclastogenesis via IL-17.
Giambartolomei GH; Scian R; Acosta-Rodríguez E; Fossati CA; Delpino MV
Am J Pathol; 2012 Sep; 181(3):887-96. PubMed ID: 22901753
[TBL] [Abstract][Full Text] [Related]
55. Depth and volume of resorption induced by osteoclasts generated in the presence of RANKL, TNF-alpha/IL-1 or LIGHT.
Mabilleau G; Pascaretti-Grizon F; Baslé MF; Chappard D
Cytokine; 2012 Feb; 57(2):294-9. PubMed ID: 22172512
[TBL] [Abstract][Full Text] [Related]
56. IL-33 Inhibits TNF-α-Induced Osteoclastogenesis and Bone Resorption.
Ohori F; Kitaura H; Ogawa S; Shen WR; Qi J; Noguchi T; Marahleh A; Nara Y; Pramusita A; Mizoguchi I
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046264
[TBL] [Abstract][Full Text] [Related]
57. IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro.
Horwood NJ; Elliott J; Martin TJ; Gillespie MT
J Immunol; 2001 Apr; 166(8):4915-21. PubMed ID: 11290769
[TBL] [Abstract][Full Text] [Related]
58. Enhanced immunoprotective effects by anti-IL-17 antibody translates to improved skeletal parameters under estrogen deficiency compared with anti-RANKL and anti-TNF-α antibodies.
Tyagi AM; Mansoori MN; Srivastava K; Khan MP; Kureel J; Dixit M; Shukla P; Trivedi R; Chattopadhyay N; Singh D
J Bone Miner Res; 2014 Sep; 29(9):1981-92. PubMed ID: 24677326
[TBL] [Abstract][Full Text] [Related]
59. Impaired bone formation and increased osteoclastogenesis in mice lacking chemokine (C-C motif) ligand 5 (Ccl5).
Wintges K; Beil FT; Albers J; Jeschke A; Schweizer M; Claass B; Tiegs G; Amling M; Schinke T
J Bone Miner Res; 2013 Oct; 28(10):2070-80. PubMed ID: 23553711
[TBL] [Abstract][Full Text] [Related]
60. IL-37 inhibits lipopolysaccharide-induced osteoclast formation and bone resorption in vivo.
Saeed J; Kitaura H; Kimura K; Ishida M; Sugisawa H; Ochi Y; Kishikawa A; Takano-Yamamoto T
Immunol Lett; 2016 Jul; 175():8-15. PubMed ID: 27154248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
